BioSpace Launches 2026 Biotech IPO Dashboard for U.S. Public Debuts
Updated
Updated · BioSpace · Jul 17
BioSpace Launches 2026 Biotech IPO Dashboard for U.S. Public Debuts
2 articles · Updated · BioSpace · Jul 17
Summary
BioSpace rolled out a new dashboard tracking U.S. biotech companies that have gone public in 2026, aiming to follow their post-IPO performance rather than just their market debut.
2026 biotech IPO activity is picking up after a prolonged slowdown in new listings, prompting demand for a centralized view of how newly public startups are trading.
Weekly Wednesday updates will add the latest closing prices and include any additional U.S. biotechs that enter the public markets during the year.